In cancer, pharmacological blockade of TREM-1 is a promising approach to target tumor-associated macrophages (TAM) (83, 84), the major innate immune cells that infiltrate solid tumors and can form up to 50% of the tumor mass (83). The gene discussed is TREM1; the disease is cancer.